Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tolentino JE"'
Publikováno v:
Diversitas Journal, Vol 9, Iss Special1 (2024)
This study focused on analyzing the situation and experiences of residents in MIMAROPA Youth Center, Poblacion, Bansud, Oriental Mindoro and the status of programs, services, and facilities. It aimed to understand the significant effects of governmen
Externí odkaz:
https://doaj.org/article/f3f57a01a81046f899a2f1cf068c51a3
Autor:
Dimaano A; Department of Biological Sciences, College of Science, The University of Santo Tomas, Philippines., Carreon KD; Department of Biological Sciences, College of Science, The University of Santo Tomas, Philippines., Camaya GS; Department of Biological Sciences, College of Science, The University of Santo Tomas, Philippines., Rondolo I; Department of Biology, School of Science and Engineering, Ateneo de Manila University, Philippines., Tolentino JE; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
Publikováno v:
Dialogues in health [Dialogues Health] 2024 Sep 12; Vol. 5, pp. 100193. Date of Electronic Publication: 2024 Sep 12 (Print Publication: 2024).
Autor:
Tolentino JE; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo 113-0033, Japan; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan., Lytras S; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo 113-0033, Japan; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK., Ito J; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo 113-0033, Japan; International Research Center for Infectious Diseases, The University of Tokyo, Tokyo 113-0033, Japan., Holmes EC; School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia., Sato K; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo 113-0033, Japan; International Research Center for Infectious Diseases, The University of Tokyo, Tokyo 113-0033, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 113-0033, Japan; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan. Electronic address: KeiSato@g.ecc.u-tokyo.ac.jp.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep; Vol. 24 (9), pp. e546. Date of Electronic Publication: 2024 Jul 24.
Autor:
Kaku Y; Division of Systems Virology, Department of Microbiology and Immunology, University of Tokyo, Tokyo 113-8654, Japan., Yo MS; Division of Systems Virology, Department of Microbiology and Immunology, University of Tokyo, Tokyo 113-8654, Japan; Institute of Medical Science, and Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 113-8654, Japan., Tolentino JE; Division of Systems Virology, Department of Microbiology and Immunology, University of Tokyo, Tokyo 113-8654, Japan; Institute of Medical Science, and Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 113-8654, Japan., Uriu K; Division of Systems Virology, Department of Microbiology and Immunology, University of Tokyo, Tokyo 113-8654, Japan., Okumura K; Division of Systems Virology, Department of Microbiology and Immunology, University of Tokyo, Tokyo 113-8654, Japan; Faculty of Liberal Arts, Sophia University, Tokyo, Japan., Ito J; Division of Systems Virology, Department of Microbiology and Immunology, University of Tokyo, Tokyo 113-8654, Japan; International Research Center for Infectious Diseases, University of Tokyo, Tokyo 113-8654, Japan., Sato K; Division of Systems Virology, Department of Microbiology and Immunology, University of Tokyo, Tokyo 113-8654, Japan; International Research Center for Infectious Diseases, University of Tokyo, Tokyo 113-8654, Japan; International Vaccine Design Center, University of Tokyo, Tokyo 113-8654, Japan; Institute of Medical Science, and Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Medicine, University of Tokyo, Tokyo 113-8654, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan; Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow, UK. Electronic address: keisato@g.ecc.u-tokyo.ac.jp.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Aug; Vol. 24 (8), pp. e482-e483. Date of Electronic Publication: 2024 Jun 27.
Autor:
Tolentino JE; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan., Lytras S; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK., Ito J; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. jampei@g.ecc.u-tokyo.ac.jp.; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. jampei@g.ecc.u-tokyo.ac.jp., Sato K; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. KeiSato@g.ecc.u-tokyo.ac.jp.; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan. KeiSato@g.ecc.u-tokyo.ac.jp.; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. KeiSato@g.ecc.u-tokyo.ac.jp.; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. KeiSato@g.ecc.u-tokyo.ac.jp.; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. KeiSato@g.ecc.u-tokyo.ac.jp.; CREST, Japan Science and Technology Agency, Kawaguchi, Japan. KeiSato@g.ecc.u-tokyo.ac.jp.; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. KeiSato@g.ecc.u-tokyo.ac.jp.; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. KeiSato@g.ecc.u-tokyo.ac.jp.
Publikováno v:
Virology journal [Virol J] 2024 Apr 10; Vol. 21 (1), pp. 84. Date of Electronic Publication: 2024 Apr 10.